Laurel Wealth Advisors Inc. Takes $214,000 Position in Thermo Fisher Scientific Inc. (TMO)

Laurel Wealth Advisors Inc. purchased a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,135 shares of the medical research company’s stock, valued at approximately $214,000.

Several other hedge funds have also recently made changes to their positions in the company. Bank of Nova Scotia Trust Co. acquired a new stake in Thermo Fisher Scientific in the 3rd quarter worth about $106,000. Zions Bancorporation lifted its stake in shares of Thermo Fisher Scientific by 4,273.4% in the 3rd quarter. Zions Bancorporation now owns 3,455 shares of the medical research company’s stock valued at $654,000 after purchasing an additional 3,376 shares in the last quarter. Cornerstone Capital Management Holdings LLC. lifted its stake in shares of Thermo Fisher Scientific by 0.6% in the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 77,143 shares of the medical research company’s stock valued at $14,594,000 after purchasing an additional 489 shares in the last quarter. Chevy Chase Trust Holdings Inc. lifted its stake in shares of Thermo Fisher Scientific by 3.4% in the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 350,867 shares of the medical research company’s stock valued at $66,384,000 after purchasing an additional 11,453 shares in the last quarter. Finally, Mastrapasqua Asset Management Inc. lifted its stake in shares of Thermo Fisher Scientific by 0.9% in the 3rd quarter. Mastrapasqua Asset Management Inc. now owns 38,521 shares of the medical research company’s stock valued at $7,288,000 after purchasing an additional 338 shares in the last quarter. Institutional investors and hedge funds own 86.05% of the company’s stock.

Shares of Thermo Fisher Scientific Inc. (NYSE TMO) opened at $192.29 on Thursday. Thermo Fisher Scientific Inc. has a twelve month low of $139.88 and a twelve month high of $201.20. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.81. The firm has a market capitalization of $77,749.00, a P/E ratio of 21.31, a PEG ratio of 1.78 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The business had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the previous year, the firm posted $2.03 EPS. The business’s revenue for the quarter was up 13.9% compared to the same quarter last year. sell-side analysts predict that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.31%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the transaction, the chief executive officer now owns 302,577 shares in the company, valued at approximately $58,016,113.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.49% of the company’s stock.

Several research firms have recently weighed in on TMO. Zacks Investment Research lowered Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Monday, September 18th. Barclays reiterated an “overweight” rating and set a $215.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a report on Monday, September 25th. Morgan Stanley reiterated an “overweight” rating and set a $220.00 target price on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. Cowen reiterated a “buy” rating and set a $200.00 target price on shares of Thermo Fisher Scientific in a report on Friday, September 1st. Finally, Jefferies Group restated a “hold” rating and set a $195.00 price objective on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. One equities research analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Thermo Fisher Scientific has an average rating of “Buy” and a consensus target price of $205.21.

COPYRIGHT VIOLATION WARNING: “Laurel Wealth Advisors Inc. Takes $214,000 Position in Thermo Fisher Scientific Inc. (TMO)” was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at https://sportsperspectives.com/2017/12/21/laurel-wealth-advisors-inc-takes-214000-position-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply